Jeffrey Borgia, Assoc. Professor, Department of Pathology, Department of Cell & Molecular Medicine, Rush University Medical Center
Dr David Boulware, Professor Of Medicine, University of Minnesota
Abby Bownas, Principal, AVAC
Dr Sarah Browne, Senior Director, Clinical Development, Altimmune
Rob Burgess, Chief Business Officer, Sino Biological Inc
Dr Dennis Burton, Chair, Department of Immunology and Microbiology, The Scripps Research Institute
David Canton, Senior Director, R&D And Clinical Science, OncoSec Medical
Sumit Chanda, Professor, Department of Immunology and Microbiology, The Scripps Research Institute
Dr Tomas Cihlar, Vice President, Virology, Gilead Sciences, Inc.
Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center
Keegan Cooke, Principal Scientist, Amgen
James Crowe, Director, Vanderbilt Vaccine Center
Dr James Crowe, Director, Vanderbilt Vaccine Center
Dr Diane Da Silva, Associate Director, Translational Medicine, Parker Institute for Cancer Immunotherapy
Dr Rea Dabelic, Market Development Manager, 10x Genomics
Heather Darby, Scientific and Applications Marketing Manager, LTG, Luminex Corporation
Dr Mindy Davis, Program Officer - Antiviral Discovery, NIH
Dr Steven Deeks, Professor of Medicine, University of California San Francisco
Manisha Diaz, Associate Director, Research and Development, Eurofins Viracor Biopharma
David Dominguez, Research Associate, Takeda
Amber Donahue, Director, Translational Medicine, Instil Bio
Dr Nathan Duval, Scientist, NTx
David Ede, Technology Consultant - Viral Based Therapeutics, Sartorius Stedim Biotech
Peter Ehrenkranz, Deputy Director, HIV Testing and Treatment, Bill & Melinda Gates Foundation
Vanessa Elharrar, Vice President, Vaccines Business Strategy Lead, ppd
Dr Tom Evans, Chief Scientific Officer, Vaccitech
Kimberly Finn, VP, Global Patient Centric Service and PM, Marken
Denise Foster, COVID-19 Vaccine Clinical Director, Chief Nursing Officer, Medical Care Services, County of San Diego Health and Human Services
Dr Felix Frueh, CSO and Co-Founder, Selva Therapeutics, Inc.
Scott Fu, Sales Specialist, InDevR
Dr Hanspeter Gerber, CSO, 3T Biosciences
Brad Gessner, Vice President, Global Medical Lead For Pneumococcal Vaccines, Pfizer
Dr Robert Gish, Managing Director, Hepatitis B. Foundation
Dr Jeffrey Glenn, Professor of Medicine and of Microbiology & Immunology, Stanford University
Dr Anna-Dorothea Gorki, CSO, G.ST Antivirals
Anna-Dorothea Gorki, CSO, G.ST Antivirals
John Gregg, CEO, Balinbac Therapeutics, Inc.
Dr Farshad Guirakhoo, Chief Scientific Officer, vaxxinity
Serhat Gumrukcu, Inventor and Co-founder, Enochian BioSciences
Kathryn Hashey, US Vaccine Policy Lead, GSK
Mary Hauser, Senior Scientist, GeoVax, Inc.
Daniel Henderson, CEO, CSO, Verndari
Ted Hibben, CBO, Vaxess
Daniel Hollern, Assistant Professor, Assistant Professor, NOMIS Center for Immunobiology and Microbial Pathogenesis, The Salk Institute
Dr Karl Hostetler, Professor of Medicine, University of California San Diego
Eric Ibsen, CEO, Studylog
Dr Michael Ison, Professor Of Medicine, Northwestern University
Dr Amy Jenkins, Program Manager, D.A.R.P.A.
Karin Jooss, CSO, Gritstone Oncology
Dr Robert Jordan, Senior Program Officer, Bill & Melinda Gates Foundation
Maria Karasarides, Vice-President, Head Early Assets & Biomarkers, Bristol-Myers Squibb
Dr Scott Kelly, CMO, CytoDyn, Inc.
Kevin Killeen, Chief Scientific Officer, Matrivax R & D Corp
Alexander Kort, SVP Corporate Development, Themis Bioscience
Tom Lake, SVP, Strategic Alliances & Commercialization, Vaxxas
Rekha Lakshmanan, Contributing Expert, Rice University’s Baker Institute for Public Policy; Director, Advocacy And Policy, The Immunization Partnership
Brandon Lamarche, Principal Scientist, Head of xCELLigence Application Development, Agilent
Christopher Larson, Vice President of Viral Therapy, EpicentRx
David F. Lasseter, Former Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction at DoD; Consultant,, Horizons Global Solutions
Dr Sam Lee, President, Cocrystal Pharma, Inc.
Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School
Dr Rachel Liberatore, Director of Research & Development, Renbio
Dr Elke Lipka, Ph.D, MBA, CEO, TSRL, Inc
Bruce Lyday, Chief Technology Officer, Primevax Immuno-Oncology, Inc.
Shelly Malhotra, Senior Director, Global Access, IAVI
Alex Mann, Senior Director, Clinical Sciences, hVIVO
Dr Tyler Martin, Chairman, President & CEO, Adjuvance Technologies
Kevin McCowen, Southwest Regional Manager, Wyatt Technology Corporation
Mark McDade, Managing Partner, Qiming Venture Partners
Dr Jonathan Mercado, Biotech Consultant, IsoPlexis
Dr James Merson, Global Therapeutic Area Head, Infectious Diseases, Janssen
Jacqueline Miller, Senior Vice President, Therapeutic Area Head, Infectious Disease, Moderna Therapeutics
Lenny Moise, Director of Vaccine Research, EpiVax Inc
Sandrine Miller Montgomery, President & CEO, Micronoma
Vincent Munster, Chief of Virus Ecology Unit, NIAID, NIH
Mark Newman, CSO, GeoVax, Inc.
Toyin Nwafor, Regional Medical Director, ViiV healthcare
Dr Neal Padte, Chief Operating Officer & Chief Development Officer, Renbio
Dr Wendy Painter, Chief Medical Officer, Ridgeback Biotherapeutics
Dr George Painter, Professor of Pharmacology and Chemical Biology, Emory University
Jason Paragas, President, SaponiQx
Dr Gaston Picchio, Chief Development Officer, Arbutus Biopharma Corporation
Robert Popovian, Senior Health Policy Fellow, Progressive Policy Institute
Krishna Prasad, Founder, Citranvi Biosciences LLC
kamal puri, CSO, OncoResponse
Dr Barbara Rath, Chair of the ISIRV Epidemiology Group and Board Member with ISIRV and ESGREV and Co-founder & Chair, Vienna Vaccine Safety Initiative
Dr Douglas Richman, Director, Center for Aids Research, University of California San Diego
Paul Robbins, Vice President, Translational Oncology, Instil Bio
Kari Roberts, Business Development Manager, Microbiologics Inc
Paul Schaper, Executive Director of Global Pharmaceutical Public Policy, Merck
Richard Scheuermann, Director, J. Craig Venter Institute
Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology
Dr Kathie Seley-Radtke, Professor Chemistry & Biochemistry, University of Maryland Baltimore County
Barbara Sennino, Senior Director, Tumor Immunology, PACT Pharma, Inc
Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Institute for Allergy and Immunology
Dr Robert Shafer, Professor of Medicine-Infectious Diseases, Stanford University School of Medicine (USA)
Sonia Sharma, Assistant Professor and Director of the Division of Cell Biology, La Jolla Institute
Dr Leah Sibener, Co-Founder, Head of Therapeutic Discovery, 3T Biosciences
Adam Simpson, Co-Founder And Chief Executive Officer, Icosavax, Inc.
William Smith, PI/CEO, Alliance for Multispecialty Research LLC
Trevor Smith, VP of Preclinical Developments, Inovio Pharmaceuticals
Tim Soos, Director Immunology, Codiak Biosciences
Dr Erin Spiegel, VP Clinical & Regulatory Affairs, PharmaJet
Mike Stebbins, Executive Director, Medical CBRN Defense Consortium
Dr Eddie Sullivan, President, Chief Executive Officer And Co-Founder, Sab Biotherapeutics Inc
Dr Todd Suscovich, Chief Technology Officer, Seromyx
Dr Pablo Tamayo, Co-Director, Cancer Center Genomics And Computational Biology Shared Resource, Professor, Division O, University of California, San Diego (UCSD)
Dr Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals
Dr Heidi Trusheim, Head of Process Development, IDT Biologika
Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart
Dr Andrew Vaillant, Chief Scientific Officer, Replicor Inc.
Prof. Wim Van Criekinge, Professor, myNEO NV
Robert Walker, Chief Medical Officer, Meissa Vaccines, Inc
Dr Laura Walker, Chief Scientific Officer, Adagio Therapeutics
James Wassil, COO, Vaxcyte
Dr Ariel Weinberger, CEO, Autonomous
Daniela Weiskopf, Instructor, Division Of Vaccine Discovery, La Jolla Institute for Allergy and Immunology
Dr Michael Wohlfeiler, Chief of Medicine, AIDS Healthcare Foundation
Mahesh Yadav, Principal Scientist, Oncology Biomarker Development, Genentech
Dr Kevin Yeo, Director, Medical Affairs,, Emergent Biosolutions
Arthur Young, President And Founder, InvVax Inc
Dr Benjamin Young, Head Of Global Medical Directors, ViiV healthcare